Antimicrobial Use and Resistance Eligible Antimicrobial Agents

$179 / year

The National Healthcare Safety Network (NHSN) Antimicrobial Use and Resistance (AUR) provides a mechanism for facilities to report and analyze antimicrobial use and/or resistance as part of local or regional efforts to reduce antimicrobial resistant infections through antimicrobial stewardship efforts or interruption of transmission of resistant pathogens at their facility.

Complexity

The primary objective of the Antimicrobial Use option is to facilitate risk-adjusted inter- and intra-facility benchmarking of antimicrobial usage. A secondary objective is to evaluate trends of antimicrobial usage over time at the facility and national levels.
This module contains two options, one focused on antimicrobial usage and the second on antimicrobial resistance. To participate in either option, facility personnel responsible for reporting antimicrobial use (AU) or resistance (AR) data to the National Healthcare Safety Network (NHSN) must coordinate with their laboratory and/or pharmacy information software providers to configure their system to enable the generation of standard formatted file(s) to be imported into NHSN. The format provided for data submission follows the Health Level (HL7) Clinical Document Architecture (CDA).

Date Created

2014-01-01

Last Modified

2020-01-31

Version

2020-01-31

Update Frequency

Irregular

Temporal Coverage

N/A

Spatial Coverage

United States

Source

John Snow Labs; Centres for Disease Control and Prevention;

Source License URL

Source License Requirements

N/A

Source Citation

Centres for Disease Control and Prevention (cdc.gov)

Keywords

Bacteria Antibiotics, Antimicrobial Resistance Research, Bacteria Antibiotics, Antimicrobial Resistance Research, Antimicrobial Use, Antimicrobial Resistant Infections

Other Titles

Antimicrobial Use and Resistance Eligible Bacteria Antibiotic Agents, Antimicrobial Resistance Research Use and Resistance Eligible Antimicrobial Agents

NameDescriptionTypeConstraints
Antimicrobial_AgentDefined as select antimicrobial agents and stratified by route of administration (i.e., intravenous, intramuscular, digestive and respiratory).stringrequired : 1 maxLength : 29
ValueThe drug values used for the development of the CDA files. "a" = RxNorm or NHSN Code.stringrequired : 1 maxLength : 7
NHSN_Drug_CodeThe list of NHSN drug codes used for the development of the CDA files.stringrequired : 1 maxLength : 14
Antimicrobial_CategoryIt defines the antimicrobial categorically.stringrequired : 1 maxLength : 22
Antimicrobial_ClassClassification of Antimicrobial agents. "b" = Adapted from CLSI January 2014.stringrequired : 1 maxLength : 43
Antimicrobial_SubclassSub classification of Antimicrobial agents. "b" = Adapted from CLSI January 2014.stringmaxLength : 38
Antimicrobial AgentValueNHSN Drug CodeAntimicrobial CategoryAntimicrobial ClassAntimicrobial Subclass
AMANTADINE620AMANAnti-influenzaM2 ion channel inhibitors
AMIKACIN641AMKAntibacterialAminoglycosides
AMIKACIN LIPOSOMAL2059180AMIKLIPAntibacterialAminoglycosides
AMOXICILLIN723AMOXAntibacterialPenicillinsAminopenicillin
AMOXICILLIN/CLAVULANATE19711AMOXWCAntibacterial?-lactam/ ?-lactamase inhibitor combination
AMPHOTERICIN B732AMPHAntifungalPolyenes
AMPHOTERICIN B LIPOSOMAL236594AMPHOTAntifungalPolyenes
AMPICILLIN733AMPAntibacterialPenicillinsAminopenicillin
AMPICILLIN/SULBACTAM1009148AMPIWSAntibacterial?-lactam/ ?-lactamase inhibitor combination
ANIDULAFUNGIN341018ANIDAntifungalEchinocandins